Clinical drug diversion is a critical issue in pharmacies and health systems nationwide. Healthcare workers who steal or misuse controlled substances (CS) cause direct harm to patients and put their employers at risk for financial penalties and sanctions.
Presented by Dwight de Vera, GM Healthcare Intelligence at Inmar, and Nick Culbertson, Co-Founder and CEO at Protenus, this webinar explores the following:
- Ways to both prevent and detect drug diversion by using advanced analytics and artificial intelligence
- Steps to establish a CS diversion prevention program in your facility
- Key Performance Indicators (KPIs) to evaluate the success of your drug diversion program
- Future integration with other Inmar solutions e.g. DSCSA (purchases), Pharmaceutical Returns and pharmacy claims and reconciliation transactions